Endocrine Testing Market Size, Trends, Analysis, and Outlook By Test (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test, Others), By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal & Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Others), By End-User (Hospitals, Commercial Laboratories, Ambulatory Care Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Endocrine Testing market size is poised to register 8.37% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Endocrine Testing market across By Test (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test, Others), By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal & Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Others), By End-User (Hospitals, Commercial Laboratories, Ambulatory Care Centers, Others).
The endocrine testing market is witnessing steady growth attributed to the growing incidence of endocrine disorders, expanding geriatric population, and advancements in laboratory medicine. Endocrine tests encompass a wide range of assays for hormones and biomarkers, enabling the diagnosis, monitoring, and treatment of conditions such as diabetes, thyroid disorders, and reproductive hormone imbalances, thereby driving market adoption across hospitals, clinics, and diagnostic laboratories.
Endocrine Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Endocrine Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Endocrine Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Endocrine Testing industry.
Key market trends defining the global Endocrine Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Endocrine Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Endocrine Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Endocrine Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Endocrine Testing industry
Leading Endocrine Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Endocrine Testing companies.
Endocrine Testing Market Study- Strategic Analysis Review
The Endocrine Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Endocrine Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Endocrine Testing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Endocrine Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Endocrine Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Endocrine Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Endocrine Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Endocrine Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Endocrine Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Endocrine Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Endocrine Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Endocrine Testing in Asia Pacific. In particular, China, India, and South East Asian Endocrine Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Endocrine Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Endocrine Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Endocrine Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Endocrine Testing.
Endocrine Testing Market Company Profiles
The global Endocrine Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AB Sciex, Abbott Laboratories, Agilent Technologies Inc, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Laboratory Corp of America Holdings, Ortho Clinical Diagnostics, Quest Diagnostics Inc
Recent Endocrine Testing Market Developments
The global Endocrine Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Endocrine Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Test
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others
By Technology
Tandem Mass Spectrometry
Immunoassay
Monoclonal & Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Others
By End-User
Hospitals
Commercial Laboratories
Ambulatory Care Centers
Others
Geographical Segmentation:
AB Sciex
Abbott Laboratories
Agilent Technologies Inc
bioMerieux SA
Bio-Rad Laboratories Inc
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Laboratory Corp of America Holdings
Ortho Clinical Diagnostics
Quest Diagnostics Inc
Formats Available: Excel, PDF, and PPT
The endocrine testing market is witnessing steady growth attributed to the growing incidence of endocrine disorders, expanding geriatric population, and advancements in laboratory medicine. Endocrine tests encompass a wide range of assays for hormones and biomarkers, enabling the diagnosis, monitoring, and treatment of conditions such as diabetes, thyroid disorders, and reproductive hormone imbalances, thereby driving market adoption across hospitals, clinics, and diagnostic laboratories.
Endocrine Testing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Endocrine Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Endocrine Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Endocrine Testing industry.
Key market trends defining the global Endocrine Testing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Endocrine Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Endocrine Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Endocrine Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Endocrine Testing industry
Leading Endocrine Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Endocrine Testing companies.
Endocrine Testing Market Study- Strategic Analysis Review
The Endocrine Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Endocrine Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Endocrine Testing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Endocrine Testing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Endocrine Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Endocrine Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Endocrine Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Endocrine Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Endocrine Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Endocrine Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Endocrine Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Endocrine Testing in Asia Pacific. In particular, China, India, and South East Asian Endocrine Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Endocrine Testing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Endocrine Testing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Endocrine Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Endocrine Testing.
Endocrine Testing Market Company Profiles
The global Endocrine Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AB Sciex, Abbott Laboratories, Agilent Technologies Inc, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Laboratory Corp of America Holdings, Ortho Clinical Diagnostics, Quest Diagnostics Inc
Recent Endocrine Testing Market Developments
The global Endocrine Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Endocrine Testing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Test
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others
By Technology
Tandem Mass Spectrometry
Immunoassay
Monoclonal & Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Others
By End-User
Hospitals
Commercial Laboratories
Ambulatory Care Centers
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AB Sciex
Abbott Laboratories
Agilent Technologies Inc
bioMerieux SA
Bio-Rad Laboratories Inc
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Laboratory Corp of America Holdings
Ortho Clinical Diagnostics
Quest Diagnostics Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Endocrine Testing Market Overview and Key Findings, 2024
1.2 Endocrine Testing Market Size and Growth Outlook, 2021- 2030
1.3 Endocrine Testing Market Growth Opportunities to 2030
1.4 Key Endocrine Testing Market Trends and Challenges
1.4.1 Endocrine Testing Market Drivers and Trends
1.4.2 Endocrine Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Endocrine Testing Companies
2. ENDOCRINE TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Endocrine Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Endocrine Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ENDOCRINE TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ENDOCRINE TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Test
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others
By Technology
Tandem Mass Spectrometry
Immunoassay
Monoclonal & Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Others
By End-User
Hospitals
Commercial Laboratories
Ambulatory Care Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Endocrine Testing Market, 2025
5.2 Asia Pacific Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Endocrine Testing Market, 2025
5.5 Europe Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Endocrine Testing Market, 2025
5.8 North America Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Endocrine Testing Market, 2025
5.11 South America Pacific Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Endocrine Testing Market, 2025
5.14 Middle East Africa Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Endocrine Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Endocrine Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Endocrine Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Endocrine Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Endocrine Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Endocrine Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Endocrine Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Endocrine Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Endocrine Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Endocrine Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Endocrine Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Endocrine Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Endocrine Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Endocrine Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Endocrine Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Endocrine Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Endocrine Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Endocrine Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Endocrine Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Endocrine Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Endocrine Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Endocrine Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Endocrine Testing Industry Drivers and Opportunities
7. ENDOCRINE TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ENDOCRINE TESTING COMPANY PROFILES
8.1 Profiles of Leading Endocrine Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AB Sciex
Abbott Laboratories
Agilent Technologies Inc
bioMerieux SA
Bio-Rad Laboratories Inc
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Laboratory Corp of America Holdings
Ortho Clinical Diagnostics
Quest Diagnostics Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Endocrine Testing Market Overview and Key Findings, 2024
1.2 Endocrine Testing Market Size and Growth Outlook, 2021- 2030
1.3 Endocrine Testing Market Growth Opportunities to 2030
1.4 Key Endocrine Testing Market Trends and Challenges
1.4.1 Endocrine Testing Market Drivers and Trends
1.4.2 Endocrine Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Endocrine Testing Companies
2. ENDOCRINE TESTING MARKET SIZE OUTLOOK TO 2030
2.1 Endocrine Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Endocrine Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ENDOCRINE TESTING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ENDOCRINE TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Test
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others
By Technology
Tandem Mass Spectrometry
Immunoassay
Monoclonal & Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Others
By End-User
Hospitals
Commercial Laboratories
Ambulatory Care Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Endocrine Testing Market, 2025
5.2 Asia Pacific Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Endocrine Testing Market, 2025
5.5 Europe Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Endocrine Testing Market, 2025
5.8 North America Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Endocrine Testing Market, 2025
5.11 South America Pacific Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Endocrine Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Endocrine Testing Market, 2025
5.14 Middle East Africa Endocrine Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Endocrine Testing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Endocrine Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Endocrine Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Endocrine Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Endocrine Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Endocrine Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Endocrine Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Endocrine Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Endocrine Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Endocrine Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Endocrine Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Endocrine Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Endocrine Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Endocrine Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Endocrine Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Endocrine Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Endocrine Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Endocrine Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Endocrine Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Endocrine Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Endocrine Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Endocrine Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Endocrine Testing Industry Drivers and Opportunities
7. ENDOCRINE TESTING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ENDOCRINE TESTING COMPANY PROFILES
8.1 Profiles of Leading Endocrine Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AB Sciex
Abbott Laboratories
Agilent Technologies Inc
bioMerieux SA
Bio-Rad Laboratories Inc
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Laboratory Corp of America Holdings
Ortho Clinical Diagnostics
Quest Diagnostics Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
